A Randomized, Double-blind, Parallel Group Study to Compare the Pharmacodynamics/Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Moderate Persistent Asthma.

Trial Profile

A Randomized, Double-blind, Parallel Group Study to Compare the Pharmacodynamics/Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Moderate Persistent Asthma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2012

At a glance

  • Drugs QAV 680 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 14 Apr 2012 New source identified and integrated (EudraCT2009-017267-41: European Clinical Trials Database).
    • 16 Sep 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Planned end date changed from 1 Dec 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top